Non-pharmacological treatments for Helicobacter pylori infection: a narrative review
DOI:
https://doi.org/10.34119/bjhrv8n4-114Keywords:
Helicobacter pylori, non-pharmacological treatment, probiotics, phytotherapy, diet, hygiene, integrative therapyAbstract
Helicobacter pylori is a gram-negative bacterium that infects over half of the world’s population, with a particularly high prevalence in low- and middle-income countries. This pathogen is directly linked to chronic gastritis, peptic ulcer disease, mucosa-associated lymphoid tissue (MALT) lymphoma, and gastric cancer. While conventional antibioticbased regimens, especially triple or quadruple therapy, have been widely used to eradicate the bacterium, antibiotic resistance, adverse effects, and high recurrence rates have created a demand for complementary treatment options. This narrative review explores the role of non-pharmacological treatments—dietary strategies, probiotics, phytotherapy, hygiene practices, and emerging alternatives—as adjuncts to standard therapy. A comprehensive search of articles published between 2015 and 2024 was performed using PubMed, PMC, and SciELO. The results indicate that non-pharmacological approaches, although not curative by themselves, may enhance eradication rates, improve patient adherence, and reduce reinfection risks. More standardized protocols and high-quality clinical trials are necessary to validate their effectiveness in clinical practice.
References
Hooi JKY et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology. 2017;153(2):420–429.
Zamani M et al. Helicobacter pylori and Gastrointestinal Disorders: An Updated Review. World J Gastroenterol. 2021;27(42):7283–7296.
Rocha GA et al. Epidemiology of Helicobacter pylori infection in children from Brazil: a systematic review. Clinics. 2021;76:e2788.
Fallone CA et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology. 2016;151(1):51–69.
Thung I et al. Review article: The global emergence of Helicobacter pylori antibiotic resistance. Aliment Pharmacol Ther. 2016;43(4):514–533.
Gatta L et al. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis. BMJ. 2013;347:f4587.
Wang F et al. Probiotics as adjunctive therapy for Helicobacter pylori eradication: a meta-analysis. J Clin Gastroenterol. 2020;54(2):107–115.
Lionetti E et al. Role of probiotics in the treatment of Helicobacter pylori infection. J Clin Gastroenterol. 2020;54(1):10–18.
Russo GL et al. Polyphenols and their effect on H. pylori infection. Molecules. 2018;23(12):3178.
Yanaka A et al. Dietary sulforaphane-rich broccoli sprouts reduce H. pylori colonization and gastric inflammation. Cancer Prev Res (Phila). 2009;2(4):353– 360.
Lu JJ et al. Anti-Helicobacter pylori activities of natural products. J Tradit Complement Med. 2013;3(4):255–261.
Zaidi SF et al. Curcumin inhibits H. pylori and protects gastric mucosa. Infect Drug Resist. 2019;12:571–578.
Basu S et al. Licorice root extract in the treatment of H. pylori: a randomized controlled trial. J Med Food. 2018;21(2):134–139.
Malaty HM. Epidemiology of Helicobacter pylori infection. Best Pract Res Clin Gastroenterol. 2007;21(2):205–214.
Goodman KJ et al. Risk factors for acquisition of Helicobacter pylori infection: a meta-analysis. Clin Infect Dis. 2005;41(4):698–704.
Shariatifar N et al. Prebiotic effects on H. pylori eradication: a randomized trial. Nutr Res Pract. 2020;14(5):428–434.
Malfertheiner P. H. pylori vaccination: Where do we stand? Gut. 2017;66(5):765–766.
